Larpent L, Verger C
Service de Biochimie, Centre Hospitalier Renè Dubos, Pontoise, France.
Perit Dial Int. 1990;10(1):89-92.
The fate of the peritoneal membrane on continuous ambulatory peritoneal dialysis (CAPD) is usually evaluated through the modification of its permeability to various solutes as glucose, creatinine, and urea. Therefore, the accuracy of the methods used for measurements of creatinine is of great importance. A particular problem does exist for creatinine determination as it may be influenced by the presence of glucose. We studied a new enzymatic colorimetric method for creatinine determination in peritoneal dialysis solutions which contain high dextrose concentrations. Creatinine was measured in plasma, urine, and dialysate from 18 patients on CAPD and in pure dextrose solutions, with an enzymatic test (Boehringer Mannheim) and with Jaffe's reaction on two different analyzers: Astra (Beckman) and Eris (Merck). Creatinine results were similar with both assays (Jaffe's reaction and enzymatic test) when measured in blood and urine. However the Jaffe's reaction gave higher creatinine results than the enzymatic test (p less than 0.001), when assays were performed in peritoneal dialysis solutions and in pure glucose solutions. In addition, it appeared that other components of dialysis solutions, mainly calcium chloride, influenced unpredictably the results of creatinine with the Jaffe's reaction. We conclude that specific enzymatic test is a more accurate and reliable method to evaluate creatinine kinetics through the peritoneal membrane when determined in CAPD solutions.
持续性非卧床腹膜透析(CAPD)时腹膜的命运通常通过其对各种溶质(如葡萄糖、肌酐和尿素)的通透性改变来评估。因此,用于测量肌酐的方法的准确性至关重要。肌酐测定存在一个特殊问题,因为它可能受葡萄糖存在的影响。我们研究了一种用于测定高葡萄糖浓度腹膜透析液中肌酐的新型酶比色法。采用酶法(勃林格殷格翰公司)以及在两种不同分析仪(贝克曼公司的Astra和默克公司的Eris)上进行的Jaffe反应,对18例CAPD患者的血浆、尿液和透析液以及纯葡萄糖溶液中的肌酐进行了测定。在血液和尿液中测量时,两种检测方法(Jaffe反应和酶法)的肌酐结果相似。然而,在腹膜透析液和纯葡萄糖溶液中进行检测时,Jaffe反应得出的肌酐结果高于酶法(p<0.001)。此外,透析液的其他成分,主要是氯化钙,似乎会不可预测地影响Jaffe反应的肌酐结果。我们得出结论,在CAPD溶液中测定时,特定的酶法是通过腹膜评估肌酐动力学的更准确、更可靠的方法。